This educational activity was developed by ADG at the request of and with funding from GSK

The recent launch in Australia of a second herpes zoster vaccine gives GPs greater scope to protect their patients against this painful and often debilitating condition. But how can doctors choose wisely between the two available options?

In this Q&A, Australian Doctor Group speaks to two vaccination experts, Associate Professor John Litt and Professor Tony Cunningham, about the risks and benefits of each vaccine and how to incorporate both into daily practice.*

Assoc Prof Litt is an academic GP, public health physician and member of the Immunisation Coalition Scientific Advisory Committee. Prof Tony Cunningham is an infectious diseases physician, clinical virologist and scientist based at the University of Sydney.